FOLLOW US |

HOME2026-04-30T14:27:57+00:00

Connecting an
International
Network

OF Academic Manufacturers
of Oncoimmunotherapies

Connecting an
International
Network

OF Academic Manufacturers
of Oncoimmunotherapies

The COST Action CINNAMON CA24115 is dedicated to expanding, harmonising, and strengthening CAR-T cell therapy expertise across Europe.

By linking academic manufacturers, clinicians, researchers, regulators, patient organisations, and industry stakeholders, CINNAMON aims to accelerate innovation, ensure equitable access, and build the foundations for decentralised CAR‑T manufacturing.

Our network brings together centres from across Europe and beyond, working collaboratively to share knowledge, develop standards, foster training, and create a robust ecosystem for advanced cellular immunotherapies.

What is CAR-T Cell Therapy?

CAR-T cell therapy is an innovative type of cancer treatment that uses a patient’s own immune cells to fight the disease. In this approach, immune cells (called T cells) are collected from the patient’s blood and genetically modified in the laboratory to better recognize and attack cancer cells.

These “retrained” cells are then returned to the patient, where they can seek out and destroy cancer.

CAR-T therapies have already shown remarkable results, particularly in some blood cancers such as leukemia, lymphoma, and multiple myeloma. Research is ongoing to expand their use to other types of cancer, including solid tumors, and to make these therapies safer, more effective, and more widely available.

Explore our Working groups

CINNAMON is composed of six Working Groups (WGs) that will work on the implementation of the Action.
WG1:
Manufacturing, scale-up,
standardization and
quality control
WG2:
Preclinical development
of novel CAR-T therapies
WG3:
Regulatory affairs and
market access
WG4:
Clinical research
WG5:
Public awareness and
patient engagement
WG6:
Training and
dissemination

Discover, Learn,
and Connect:
Explore Our
Activities

Join workshops, webinars, and
interactive sessions designed to
inspire, educate, and bring our
community together.

What’s New

WHAT IS COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST ACTION CA24115

The CINNAMON COST Action aims to set up a collaborative and interconnected network of centres dedicated to standardizing, expanding, and optimising CAR-T cell therapy expertise and capabilities.

ACTION DETAILS

MoU – 024/25
CSO Approval date: 19/05/2025
Start date: 31/10/2025
End date: 30/10/2029

Privacy policy  |  Cookies policy  |  Legal notice  | CINNAMON copyright 2026 |  Design by Comunicka

Go to Top